CAMpania PugliA bRanch Iliaco
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorFederico II University
About this trial
Spontaneus Multicentric Observational registry to investigate the medium and long-term performances of the Iliac E-liac Branch Device from Artivion for treatment of Aortoiliac aneurysms in a real-world consecutive patients cohort.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
An aortoiliac or aortic aneurysm of surgical interest based on the most recent local guidelines treated with the E-liac stent-graft system, alone or in combination with other devices
Disqualifiers
Patient's refusal to be enrolled in the registry
Patient treated with devices not including the E-liac stent-graft system
Trial population
Patients feferred to the insitution
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Evar
Procedure/SurgeryBranch Evar with the e-liac device
Treatment groups
200 Participants
are divided into 1 treatment groupGroup A: MAIN1 intervention
Trial outcomes
Primary outcomes
1
Aneurysm related death
Aneurysm related death
Time frame
assessed after procedure at 30 days, 6 months, one year, two years, three years, four years, five years.2
Procedure-related re intervention
Procedure-related re intervention
Time frame
assessed after procedure at 30 days, 6 months, one year, two years, three years, four years, five yearsSecondary outcomes
1
Aneurysm sac dynamics
Variation in aneurysm sac diameter
Time frame
assessed after procedure at 30 days, 6 months, one year, two years, three years, four years, five yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Federico II University
Lead sponsor
University of Bari
Collaborator
Source ClinicalTrials.gov